The University Hepatitis Center research department at Bach and Godofsky is the only facility of its kind in this area, and Dr. Godofsky is proud that its connections can benefit patients. “We are involved with a large number of FDA-sponsored clinical trials researching new treatments for patients treating chronic hepatitis C, chronic hepatitis B and HIV.” he explains.
“Our patients can benefit from new options that are generally only offered at university specialty centers.” The University Hepatitis Center currently partners with Duke University School of Medicine, Johns Hopkins and Mount Sinai School of Medicine in New York, among many others.
At the University Hepatitis Center research department, Dr. Godofsky delivers state-of-the-art care as well as special hope for patients with chronic virus infections. “Hepatitis C affects four million people in the United States,” he says, “but many of them don’t even realize that treatment is available with the potential for a cure.”